UBS analyst Andrew Mok raised the price target on HCA Healthcare Inc (NYSE: HCA) to $635.00 (from $598.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE